127 related articles for article (PubMed ID: 11588126)
1. Abnormal Pap smear follow-up in a high-risk population.
Engelstad LP; Stewart SL; Nguyen BH; Bedeian KL; Rubin MM; Pasick RJ; Hiatt RA
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1015-20. PubMed ID: 11588126
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of screening for cervical cancer in an inpatient hospital setting.
Trimble CL; Richards LA; Wilgus-Wegweiser B; Plowden K; Rosenthal DL; Klassen A
Obstet Gynecol; 2004 Feb; 103(2):310-6. PubMed ID: 14754701
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
4. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
Sirovich BE; Gottlieb DJ; Fisher ES
J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
[TBL] [Abstract][Full Text] [Related]
5. Health literacy as a predictor of follow-up after an abnormal Pap smear: a prospective study.
Lindau ST; Basu A; Leitsch SA
J Gen Intern Med; 2006 Aug; 21(8):829-34. PubMed ID: 16881942
[TBL] [Abstract][Full Text] [Related]
6. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.
Elit L; Krzyzanowska M; Saskin R; Barbera L; Razzaq A; Lofters A; Yeritsyan N; Bierman A
Can Fam Physician; 2012 Jan; 58(1):e22-31. PubMed ID: 22267636
[TBL] [Abstract][Full Text] [Related]
7. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?
Melnikow J; Chan BK; Stewart GK
Arch Fam Med; 1999; 8(6):510-4. PubMed ID: 10575390
[TBL] [Abstract][Full Text] [Related]
8. Enhancing adherence following abnormal Pap smears among low-income minority women: a preventive telephone counseling strategy.
Miller SM; Siejak KK; Schroeder CM; Lerman C; Hernandez E; Helm CW
J Natl Cancer Inst; 1997 May; 89(10):703-8. PubMed ID: 9168185
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
[TBL] [Abstract][Full Text] [Related]
10. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies.
Marcus AC; Crane LA; Kaplan CP; Reading AE; Savage E; Gunning J; Bernstein G; Berek JS
Med Care; 1992 Mar; 30(3):216-30. PubMed ID: 1538610
[TBL] [Abstract][Full Text] [Related]
11. The costs of an outreach intervention for low-income women with abnormal Pap smears.
Wagner TH; Engelstad LP; McPhee SJ; Pasick RJ
Prev Chronic Dis; 2007 Jan; 4(1):A11. PubMed ID: 17173719
[TBL] [Abstract][Full Text] [Related]
12. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
13. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
[TBL] [Abstract][Full Text] [Related]
14. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
15. Improving the performance of reflex Human Papilloma Virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): A restrospective study in a tertiary hospital in United Arab Emirates (UAE).
Fakhreldin M; Elmasry K
Vaccine; 2016 Feb; 34(6):823-30. PubMed ID: 26747717
[TBL] [Abstract][Full Text] [Related]
16. Impact of Patient-Directed Cytology Results Correspondence Program on Follow-Up of High-Grade Pap Tests.
Tavasoli SM; Kane E; Kupets R
J Obstet Gynaecol Can; 2019 Oct; 41(10):1461-1469. PubMed ID: 31053566
[TBL] [Abstract][Full Text] [Related]
17. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer screening in an urban emergency department.
Hogness CG; Engelstad LP; Linck LM; Schorr KA
Ann Emerg Med; 1992 Aug; 21(8):933-9. PubMed ID: 1497160
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a breast and cervical cancer screening program in a public hospital emergency department. Cancer Control Center of Harlem.
Mandelblatt J; Freeman H; Winczewski D; Cagney K; Williams S; Trowers R; Tang J; Kerner J
Ann Emerg Med; 1996 Nov; 28(5):493-8. PubMed ID: 8909269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
